Max Health stock: CARE reaffirms ratings while consensus target stands at INR 1,153.69

Published on 10/20/2026 at 17:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 15.2 percent in the first quarter. Max Health stock was INR 830.00 on NSE, October 19, 2026, down 1.89 percent versus INR 846.00.

Analyst target and reporting date

CARE reaffirmed Max Healthcare Institute ratings on October 9, 2026, while the consensus target was INR 1,153.69.
Fiscal 2027 first-quarter revenue reached INR 23.66 billion, and net income was INR 3.22 billion.
Max Health stock was INR 830.00 on the NSE on October 19, 2026, down 1.89 percent versus INR 846.00.
A general meeting was scheduled for October 21, 2026.

Max Health, INE027H01010, Illustration mit AI erstellt.

Max Health stock: CARE reaffirmed its ratings for Max Healthcare Institute on October 9, 2026, while the consensus target stood at INR 1,153.69. MarketScreener listed 27 analysts and a target 39.00 percent above the NSE price of INR 830.00. The stock was down 1.89 percent versus the prior close of INR 846.00 on October 19, 2026.

First-quarter revenue reached INR 23.66 billion

Max Healthcare reported fiscal 2027 first-quarter revenue of INR 23.66 billion and net income of INR 3.22 billion. The company also reported operating profit of INR 4.67 billion for the quarter. These figures put the latest quarter ahead of the fiscal 2026 fourth-quarter revenue of INR 21.43 billion, an increase of 10.42 percent.

The company operates 21 healthcare facilities with more than 6,100 beds across India, alongside homecare and pathology businesses. Its investor page also identifies Abhay Soi as chairman and managing director. Max Healthcare described the network and its operating businesses on the investor page.

Stock sits near its 52-week low

At INR 830.00, the NSE price was 0.17 percent above the 52-week low of INR 828.60 and 32.09 percent below the high of INR 1,221.90. The market capitalization was INR 807.8 billion, while the price-to-earnings ratio stood at 55.67 on October 19, 2026. The price position makes the analyst target a measurable valuation reference rather than a simple headline forecast.

October 21 meeting is the next date

A general meeting was scheduled for October 21, 2026, according to the corporate-actions calendar reported by Economic Times. The next quarterly reporting date was listed as October 30, 2026 by Finanzen, for the quarter ended September 30, 2026.

What the valuation reference means

The consensus target of INR 1,153.69 was 39.00 percent above the October 19 NSE price, calculated from the two INR values. The comparison leaves earnings delivery and the timing of new capacity as the central metrics for the next reporting cycle.